TP53 and cancer: Our previous study reveals that dysfunction of p53 attenuates OXPHOS by downregulating the miR-200c-PCK2 axis in BLBC (11), providing robust evidence for the causal link between Mutp53-mediated metabolic reprogramming and cancer stemness.